DE69925911D1 - Immunodiagnostischer wirkstoff zum nachweiss von maedi-visna virus und caev infektionen - Google Patents

Immunodiagnostischer wirkstoff zum nachweiss von maedi-visna virus und caev infektionen

Info

Publication number
DE69925911D1
DE69925911D1 DE69925911T DE69925911T DE69925911D1 DE 69925911 D1 DE69925911 D1 DE 69925911D1 DE 69925911 T DE69925911 T DE 69925911T DE 69925911 T DE69925911 T DE 69925911T DE 69925911 D1 DE69925911 D1 DE 69925911D1
Authority
DE
Germany
Prior art keywords
caev
maedi
immunodiagnostic
infections
review
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69925911T
Other languages
English (en)
Other versions
DE69925911T2 (de
Inventor
Lorenzo Gonzalez
Francesco Tolari
Neil Watt
Gordon Harkiss
Beatriz Amorena
Eric Saman
Eynde Geertrui Van
Diez Juan Jose Badiola
Belen Extramiana
Enrico Bollo
A Juste
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Europe NV SA
Original Assignee
Innogenetics NV SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics NV SA filed Critical Innogenetics NV SA
Application granted granted Critical
Publication of DE69925911D1 publication Critical patent/DE69925911D1/de
Publication of DE69925911T2 publication Critical patent/DE69925911T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69925911T 1998-04-30 1999-04-26 Immunodiagnostischer wirkstoff zum nachweiss von maedi-visna virus und caev infektionen Expired - Lifetime DE69925911T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98870101A EP0953574A1 (de) 1998-04-30 1998-04-30 Immundiagnostischer Wirkstoff zum Nachweiss von Maedi-Visna Virus und CAEV Infektionen
EP98870101 1998-04-30
PCT/EP1999/002810 WO1999057141A1 (en) 1998-04-30 1999-04-26 Immunodiagnostic reagent for the detection of maedi-visna virus and caev infection

Publications (2)

Publication Number Publication Date
DE69925911D1 true DE69925911D1 (de) 2005-07-28
DE69925911T2 DE69925911T2 (de) 2006-04-27

Family

ID=8237038

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69925911T Expired - Lifetime DE69925911T2 (de) 1998-04-30 1999-04-26 Immunodiagnostischer wirkstoff zum nachweiss von maedi-visna virus und caev infektionen

Country Status (8)

Country Link
EP (2) EP0953574A1 (de)
AT (1) ATE298347T1 (de)
AU (1) AU3823399A (de)
DE (1) DE69925911T2 (de)
DK (1) DK1073676T3 (de)
ES (1) ES2245100T3 (de)
PT (1) PT1073676E (de)
WO (1) WO1999057141A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005502334A (ja) * 2001-08-07 2005-01-27 メルク　エンド　カムパニー　インコーポレーテッド 生物学的アッセイ検出方法
ES2387243B1 (es) * 2010-11-30 2013-07-31 Universidad Publica De Navarra Péptidos para detectar estirpes de lentivirus
EA035265B1 (ru) * 2013-10-02 2020-05-21 Бёрингер Ингельхайм Энимал Хелс Ю-Эс-Эй Инк. Вариант белка opc2 pcv2 и содержащие его вирусоподобные частицы

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2586427B1 (fr) * 1985-08-20 1988-12-09 Pasteur Institut Sequences de nucleotides et de polypeptides issus du virus visna et leur application a des essais de diagnostic et a la production de compositions immunogenes
IE64286B1 (en) * 1988-05-25 1995-07-26 Boehringer Mannheim Gmbh Process for the determination of an immunologically detectable substance and a suitable vessel therefor
DE3901857A1 (de) * 1989-01-23 1990-07-26 Boehringer Mannheim Gmbh Verfahren zur bestimmung von hiv 2 antikoerpern
FR2721618B1 (fr) * 1994-06-28 1996-09-13 Centre Nat Rech Scient Fragments d'acide nucléique et fragments peptidiques correspondants issus du génome du virus de l'arthrite et de l'encéphalite caprine (VAEC) et leurs applications.
FR2732346B1 (fr) * 1995-03-27 1997-05-30 Centre Nat Rech Scient Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques inclus dans lesdites proteines, vecteurs d'expression exprimant lesdites proteines mutees et leurs applications

Also Published As

Publication number Publication date
AU3823399A (en) 1999-11-23
ES2245100T3 (es) 2005-12-16
EP1073676B1 (de) 2005-06-22
EP1073676A1 (de) 2001-02-07
DE69925911T2 (de) 2006-04-27
PT1073676E (pt) 2005-11-30
DK1073676T3 (da) 2005-10-17
WO1999057141A1 (en) 1999-11-11
EP0953574A1 (de) 1999-11-03
ATE298347T1 (de) 2005-07-15

Similar Documents

Publication Publication Date Title
ATE536406T1 (de) Neuartiger zytokin-zcytor17-ligand
NZ566020A (en) Prion-specific peptoid reagents
ATE263778T1 (de) Niedrigallergene proteinvarianten
IT1227907B (it) Procedimento per la sintesi di peptidi retro-inversi e nuovi intermediin tale procedimento
DE19975066I2 (de) Rekombinanter Abk¦mmling des menschlichen Faktors III.
DK1908772T3 (da) Polypeptider og polynucleinsyrer af phorphorymonas gingivalis
DE60229499D1 (de) Transfektions-komplexe
DK1114156T3 (da) Transformerende vækstfaktor Beta-9 (ZTGFSS9) fra pattedyr
DE60237791D1 (de) Zytokinproteinfamilie
DE69925911D1 (de) Immunodiagnostischer wirkstoff zum nachweiss von maedi-visna virus und caev infektionen
DK1127064T3 (da) Hidtil ukendte aminosyresekvenser, DNA, der koder for aminosyresekvenserme, antistoffer, der er rettet mod sådanne sekvenser, og forskellige anvendelser deraf
DE68923746D1 (de) Protein-Derivate und Verfahren zu ihrer Herstellung.
ES2079054T3 (es) Peptidilhidroxiglicina n-c-liasa y adn codificante de la misma.
EP1308512A4 (de) Neuartige proteine und deren dna
WO2002029053A1 (fr) Nouvelle proteine de recepteur couple a la proteine g et adn correspondant
BR0107799A (pt) Proteìna de interação de wt1 wtip
EP0953642A4 (de) Antigenprotein aus infektiöse laryngotracheitis viren
NZ606260A (en) Novel polypeptides involved in immune response

Legal Events

Date Code Title Description
8364 No opposition during term of opposition